Navigation Links
New, Published GELNIQUE Data Show Efficacy, Convenience and Excellent Tolerability
Date:3/16/2009

CORONA, Calif., March 16 /PRNewswire-FirstCall/ -- New Phase 3 data, published in the April issue of The Journal of Urology, show that GELNIQUE(TM) (oxybutynin chloride) Gel 10%, the first and only topical gel approved for the treatment of overactive bladder (OAB), is effective at improving the symptoms of urge urinary incontinence, urgency and frequency, and is extremely well tolerated in adults.

GELNIQUE is a quick drying, clear and colorless, fragrance-free gel containing oxybutynin hydrochloride developed and marketed by Watson (NYSE: WPI), a leader in generic and specialty branded pharmaceuticals. Because the active ingredient in GELNIQUE is delivered transdermally, it is not metabolized by the liver in the same way as orally administered oxybutynin. This unique dosing results in a low level of side effects, such as dry mouth and constipation.

"The study data reveal that this innovative gel formulation provides the highly desired combination of efficacy and tolerability when utilized to treat symptoms of overactive bladder," said David R. Staskin, MD, associate professor of urology at Tufts University School of Medicine and Caritas - St. Elizabeth's Medical Center and lead author of the study. "GELNIQUE has the potential to be a very important option for the treatment of patients who suffer from problems with bladder control."

Clinical Data

The double-blind, placebo-controlled study included 789 men and women with urge-predominant urinary incontinence (UI) from 76 clinics across the U.S. Patients reported a mean 5.4 daily UI episodes and a mean daily urinary frequency of 12.2-12.4. The majority of participants were women (89.2 percent).

Patients were randomized to receive either 1 gram of GELNIQUE (n=389) or a matching placebo gel (n=400) once daily fo
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
2. Adlyfe Study on the Detection of Misfolded Proteins Published in the Journal Transfusion
3. Nebivolol Lowers Blood Pressure in Mild-to-Moderate Hypertensive Patients as Demonstrated in a Study Published in the Journal of Clinical Hypertension
4. Results from Study Evaluating PROCRIT(R) in Intensive Care Unit Patients Published in New England Journal of Medicine
5. Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
6. Study Published in Endocrinology Reports Potential of Modigene Technology to Extend Duration of Protein Drugs
7. New Data Published in Neurology Show Once-Daily Lamictal XR Significantly Reduced Partial Seizures in Patients with Epilepsy
8. Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine
9. Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
10. UPDATE: Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
11. Tumor Eradication Article Published by Cancer Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... -- Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL ) today ... Bank Health Care Conference to be held May 29-30 ... Adrian Adams , Chief Executive Officer and President, ... and its product pipeline at 12:00 p.m. ET on ... http://photos.prnewswire.com/prnh/20101202/MM10881LOGO ) The presentation will also be ...
(Date:5/24/2013)... and BOSTON , May 24, 2013 ... and development company, is pleased to announce that it has engaged ... augment the Company,s business development capabilities in Japan ... than 15 years of experience in business development, licensing and alliance ... Inc., Roche Pharma ( Japan ), Nippon Roche and ...
(Date:5/23/2013)... 23, 2013 Neurocrine Biosciences, Inc. (Nasdaq: ... , President and Chief Executive Officer of Neurocrine Biosciences, will ... dbAccess Health Care Conference in Boston.   The ... a.m. Eastern Time / 8:20 a.m. Pacific Time.  The presentation ... website at http://www.neurocrine.com . If you ...
Breaking Medicine Technology:Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 2Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 3Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 4Heptares Augments Business Development Capabilities in Japan and Other Asian Territories 2
... Jan. 25, 2012 Boston IVF, a leading medical ... it has introduced the first needle-free saliva test that ... treatment. Following nearly two years of research, Boston IVF ... the blood, can also be accurately measured in saliva, ...
... FORT COLLINS, Colo., Jan. 25, 2012  Integware today ... Systems Integrator Partnership Agreement with Siemens PLM Software, ... (PLM) software and services. Integware has focused for ... product-related processes in the medical device industry. Its ...
Cached Medicine Technology:Boston IVF Pioneers World's First Needle-Free Saliva Test Used in Infertility Treatment; Patient Friendly Monitoring Replaces Daily Blood Tests 2Boston IVF Pioneers World's First Needle-Free Saliva Test Used in Infertility Treatment; Patient Friendly Monitoring Replaces Daily Blood Tests 3Integware Announces Systems Integrator Agreement With Siemens PLM Software 2
(Date:5/24/2013)... -- Nearly three out of four pregnant women ... but these issues don,t significantly affect their quality ... from Loyola University Medical Center in Maywood, Ill., ... physiological and hormonal changes that occur during pregnancy. ... can play a role. The study authors added ...
(Date:5/24/2013)... to the new market research report “Micro Irrigation System ... by MarketsandMarkets, global micro irrigation system market expected to ... 2010 and is expected to reach $3,414.7 million by ... to 2016. , Browse:, , 150 ... 370 pages and in-depth Table Of Content ...
(Date:5/24/2013)... Toronto, ON (PRWEB) May 24, 2013 ... for hosted voice, video, data, and IT security ... ability to reduce communication costs by more than ... Via a Limited Time Hosted PBX Bundle Pricing. ... the nation in touch with VoIP. , Starting ...
(Date:5/24/2013)... CA (PRWEB) May 24, 2013 Chronic ... illness that plagues sufferers with unexplained fatigue lasting 6 ... include short term memory and concentration impairment, muscle and ... tender lymph nodes, un-refreshing sleep and malaise that lasts ... obesity are now known to be linked to insulin ...
(Date:5/24/2013)... NS (PRWEB) May 24, 2013 Today ... the all-new online Itinerary Builder. , The redesigned ... easily create unique vacation itineraries on their computer or ... , The interactive tool allows users to fill ... then browse through and select their choice of vacation ...
Breaking Medicine News(10 mins):Health News:Bowel Issues Affect 3 Out of 4 Pregnant Women 2Health News:Micro Irrigation System Market to Reach $3414.7 Million by 2016 at a CAGR of 17.9% - New Report by MarketsandMarkets 2Health News:Micro Irrigation System Market to Reach $3414.7 Million by 2016 at a CAGR of 17.9% - New Report by MarketsandMarkets 3Health News:BroadConnect Is Offering New Hosted PBX Bundle Pricing for New Customers, Eliminating VoIP Adoption Barriers 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces New hCG Diet Plans to Promote Fast Weight Loss Shown to Reduce the Risk & Symptoms of Chronic Fatigue 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces New hCG Diet Plans to Promote Fast Weight Loss Shown to Reduce the Risk & Symptoms of Chronic Fatigue 3Health News:Create and Win the Perfect Halifax Getaway with the All-New Itinerary Builder 2
... for,Nursing is collaborating with a number of national ... Advanced Practice Registered Nurses,(APRNs) have on healthcare quality ... kind in 20 years, researchers will examine the,evidence ... four APRN roles --,Clinical Nurse Specialists, Nurse Anesthetists, ...
... a nationwide study to explore an investigational treatment for ... Emphysema) Trial focuses on airway bypass, a minimally invasive ... of breath typical complications of emphysema - by ... lungs. , During the airway bypass procedure, ...
... As Senators Barack,Obama and John McCain arrive in Oxford, ... by AIDS activists from across the,country demanding that the ... 100 days in office., On Friday, September 26, ... -,AIDS activists will hold a demonstration and mock funeral ...
... is reminding,all Los Angeles residents that they have just one ... enforcement begins on October 1,2008., On February 12, 2008, ... requires all cats and dogs in the City to be ... specific exemptions allowed. Mayor,Villaraigosa signed this ordinance into law on ...
... The U.S. Pharmacopeial (USP) Convention is pleased ... Reference Material (CRM), Dextromethorphan Hydrobromide. USP recently became ... for Standardization accreditation as producer of chemical CRMs. ... a new class of reference standard that ensures ...
... of liver cirrhosis is still high, although new ... no established therapy for liver fibrosis, and Authors ... Soup on liver fibrosis induced by DMN in ... fibrosis resulted from chronic liver injure, retard the ...
Cached Medicine News:Health News:27 National Nursing Organizations Join Together to Commission a Study of the Impact of Advanced Practice Registered Nurses on Healthcare Quality, Safety, and Effectiveness 2Health News:27 National Nursing Organizations Join Together to Commission a Study of the Impact of Advanced Practice Registered Nurses on Healthcare Quality, Safety, and Effectiveness 3Health News:Potential treatment option for severe emphysema under study 2Health News:AIDS Activists from Across the Country Converge on Oxford, Mississippi, to Call on McCain and Obama to Commit to National AIDS Strategy 2Health News:New Los Angeles Spay and Neuter Law Goes Into Effect on October 1 2Health News:An effective strategy for inhibition of cirrhosis 2
The Mini Vidas is a compact version of the Vidas system with a built-in computer, keyboard and printer. Two independent sections each accept six tests and can process up to 12 samples simultaneously....
The Mini Vidas is a compact version of the Vidas system with a built-in computer, keyboard and printer. Two independent sections each accept six tests and can process up to 12 samples simultaneously....
The ACE Alera clinical chemistry system serves a wide variety of chemistry diagnostic needs with the power of a large floor model analyzer in an easily integrated and economizing compact footprint of...
... For physicians looking for a ... advanced communications with electronic storage ... the best of both worlds. ... easy-to-use features of the Atria ...
Medicine Products: